Samumed is a leader in medical research and development for tissue-level regeneration. With our platform's origins in small molecule-based Wnt pathway modulation, we develop therapeutics to address a range of degenerative diseases, regenerative medicine and oncology.
View Top Employees from Samumed, LLCWebsite | http://www.samumed.com |
Revenue | $40 million |
Funding | $442 million |
Employees | 99 (37 on RocketReach) |
Founded | 2008 |
Address | 9360 Towne Centre Drive, San Diego, California 92121, US |
Phone | (858) 926-2900 |
Industry | Biotechnology, Pharmaceuticals, Science and Engineering, Information Technology and Services, Healthcare, Business Services, Health Care, Life Science |
Web Rank | 2 Million |
Keywords | Samumed, Samumed Stock, Samumed Jobs, Samumed Fibrosis, Samumed, Llc |
Competitors | Astex Pharmaceuticals, Inc. (US), Boston Life Sciences Inc, Enzon Pharmaceuticals, Orphazyme A/S, Osiris Therapeutics |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541714 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies |
Looking for a particular Samumed, LLC employee's phone or email?
The Samumed, LLC annual revenue was $40 million in 2023.
David Cummings is the Senior Director, Regulatory CMC of Samumed, LLC.
37 people are employed at Samumed, LLC.
Samumed, LLC is based in San Diego, California.
The NAICS codes for Samumed, LLC are [541714, 5417, 54171, 54, 541].
The SIC codes for Samumed, LLC are [873, 87].